Kamfanin Pfizer na Amurka, yana aiki tare da Valneva na Faransa, ya bayyana aniyarsu ta neman amincewar hukumomin da suka dace don rigakafin cutar Lyme, bayan nasarar gwaje-gwajen lafiya a matakai masu tasowa. Wannan mataki na zuwa a lokacin da sha'awar al'umman masana kiwon lafiya a hanyoyin sabbin dawo daga wannan cuta ke karuwa, wanda ke yi wa lafiyar jama'a barazana a duniya baki daya.
Gwaje-gwajen suka bayyana sakamako masu kyau wanda ke tabbatar da ingancin rigakafin da kuma babban safiyo. Cutar Lyme tana haddasa radadin gwiwa da kuma illoli masu tsanani ga lafiyar jiki, tana yaduwa ta hanyar karnuka da ke yawo a cikin yanayi mai dumi.
Bayanai Game da Matar
Pfizer da Valneva sun gudanar da gwaje-gwaje a kasashe da dama, inda aka yi nazari kan tasirin rigakafin a fadin duniya. Sakamakon farko sun nuna nasarar rigakafin a wajen karfafa tsarin garkuwar jiki don yaƙar kwayoyin cutar, wanda hakan ya ba da fata ga sabuwar jeri na rigakafi da zai iya rage yaduwar cutar.
Hakan ya karfafa gwiwar likitoci, tunda cutar Lyme na karuwa a duniya, musamman a Amurka da wasu kasashen Turai. Ana kiyasta sabbin shahararrun lokuta shekara-shekara sun kai cikin miliyoyin, wanda ke haifar da matsi a kan tsarin kiwon lafiya.
Asalin Labarin da Kwatancen
Cutar Lyme ta bayyana a karni na 70 a Amurka, kuma tun daga lokacin ta sami karuwar masu shafa yawa a duk faɗin duniya. Wannan cutar tana samuwa ne daga kwayar cuta mai suna Borrelia burgdorferi, wanda ke haifar da alamomi da dama daga zazzabi zuwa ciwon jiki wanda idan ba a kula dashi zai iya haifar da matsaloli na zuciya da na jijiyoyi.
Da karuwar sanin wannan cutar, kasashe da dama sun karkata zuwa bincike da bunkasa sabbin rigakafi, inda annobar COVID-19 ta zama babban abin ban sha'awa don zuba jari a fagen bincike da bunkasa rigakafi ga cututtukan dindindin da sabbin cututtuka.
Illoli da Tasirin Cutar
Idan aka ba wa rigakafin Lyme amincewa daga hukumomin lafiya, wannan na iya zama babbar sauyi a yadda ake yaƙar cutar. Tattaunawar rigakafi mai inganci zai rage nauyin lafiya da na tunani ga wadanda suka kamu da cutar, da kuma iyalansu da tsarin kiwon lafiya gaba daya.
Hakanan, wannan ci gaban na taimakawa wajen karfafa gwiwar jama'a a kan kamfanonin magunguna, wanda aka traftare a baya saboda jinkirin fitar da rigakafi. Wannan haɗin gwiwa a tsakanin Pfizer da Valneva yana nuna wani misali na yadda za a yi saurin inganta rigakafi da inganci.
Tasirin a Yankin Gabas ta Tsakiya
Haka nan, yankin Gabas ta Tsakiya na fuskantar karuwar rajistar cutar Lyme, inda yanayin muhalli da salo na rayuwa ke taka rawar gani wajen inganta hozon karnuka. Samun amincewa ga rigakafin mai inganci a kasuwar duniya na ba da fata ba kawai a kan yaki da wannan cuta, har ma wajen inganta matakin lafiya da tsaro a kasashen Larabawa.
Duk da haka, tsare-tsaren kariya da ilmantar da jama'a kan hanyoyin tabbatar da kariya daga karfafa da ke zama wajibi, saboda gudanar da allurai ga al'ummar kan wannan cuta zai bukaci kokarin gaggawa da na gina jiki daga gwamnati da kungiyoyin lafiya.